FDA Investigator Yvette I Johnson
Yvette I Johnson has conducted inspections on 14 sites in 5 countries as of 04 Jan 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
14
Last Inspection Date:
04 Jan 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
China,
Australia,
Korea (Republic of),
Switzerland,
United States of America
FDA Investigators that have inspected at least one site in common with Yvette I Johnson:
Anita R Michael,
Anthony A Charity,
Arsen Karapetyan,
Brandy N Lepage,
CDR Ileana Barreto Pettit,
Charles I Ann,
Charles M Edwards,
Chiang Syin, PhD,
Christina K Theodorou,
Constantin Y Philopoulos,
Dawn E Barkans,
Debra L Pagano,
Douglas C Kovacs,
Dr. Mark J Seaton, PhD,
Dr. Robert C Horan, MD,
Edwin Martinez,
Edwin Melendez,
Farhana Khan,
George Pyramides,
Guerlain Ulysse,
Guo Q Shen,
Gwyn G Dickinson,
Herbert M Corbello,
James C Maclaughlin,
Jeffery A Hangartner,
Joanne Hajoway,
Joanne M Hajoway,
John D White,
Jonathan W Chapman,
José E Meléndez,
Jose R Hernandez,
Joshua P Wireman,
Justin A Boyd,
Kara D Dobbin,
Karl D Hezel,
Katherine Szestypalow,
Kent C Faul,
Kham Phommachanh,
Kristen D Evans,
Kristina J Donohue,
Larry K Austin,
LCDR Chad N Thompson,
Maria A Reed,
Mary E Storch,
Matthew B Casale,
Meredith P Soehl, Investigator,
Michael A Taylor,
Michael D Omeara,
Michele L Obert,
Michele M Falchek,
Nicole E Knowlton,
Paraluman S Leonin,
Parul M Patel,
Paul L Bellamy,
Peter C Chow,
Peter E Baker,
Prabhu P Raju,
Rachael A Moliver,
Ralph H Vocque,
Reba A Gates,
Richard H Penta,
Richard L Friedman,
Robert D Tollefsen,
Rochelle L Cross,
Roger F Zabinski,
Rozelle G Smith,
Sarah E Mcmullen,
Simone E Pitts,
Sony Mathews,
Steven P Donald,
Susan T Hadman,
Susan W Ting,
Tammy L Chavis,
Teresa I Navas,
Thomas J Arista,
Tiffani D Wilson,
Vlada Matusovsky,
Yvette I Henry,
Zedong Dong,
Zi Qiang Gu
Yvette I Johnson's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more